Literature DB >> 19962371

Methamphetamine self-administration and the effect of contingency on monoamine and metabolite tissue levels in the rat.

Katharine A Brennan1, Joyce Colussi-Mas, Caleb Carati, Rod A Lea, Paul S Fitzmaurice, Susan Schenk.   

Abstract

A number of studies have shown that exposure to high doses of methamphetamine (MA) is toxic to central dopamine (DA) and serotonin (5-HT) neurons. In most of those studies, however, high doses of MA were experimenter-administered during a short exposure time. Because contingency is a determinant for many effects of drug exposure, the present objective was to investigate the effects of self-administered MA on tissue monoamine levels following a short (24 hours) or longer (7 days) withdrawal period. As previously reported, a noncontingent "binge" high-dose treatment regimen (4 injections of 10 mg/kg MA administered every 2 hours) produced persistent depletion of cortical 5-HT and striatal DA. Effects of self-administered MA (0.1 mg/kg/infusion) were then determined following a 20-day duration where a yoked design was employed such that some rats received MA contingent on an operant lever press and others received either MA or saline dependent on the responses of the contingent rat. Self-administered MA produced a transient striatal DA depletion with a more persistent increase in DA turnover, indicating the presence of some lasting adaptations. Furthermore, the yoked design revealed that there was no effect of contingency on these parameters. 2009. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962371     DOI: 10.1016/j.brainres.2009.11.069

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure.

Authors:  Lisa M McFadden; Paula L Vieira-Brock; Glen R Hanson; Annette E Fleckenstein
Journal:  Neuropharmacology       Date:  2015-01-31       Impact factor: 5.250

2.  Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine.

Authors:  Melissa L Barker-Haliski; Katharina Oldenburger; Kristen A Keefe
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

3.  Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats.

Authors:  Julie A Marusich; Elaine A Gay; Bruce E Blough
Journal:  Psychopharmacology (Berl)       Date:  2018-09-06       Impact factor: 4.530

4.  Tobacco's minor alkaloids: Effects on place conditioning and nucleus accumbens dopamine release in adult and adolescent rats.

Authors:  Julie A Marusich; Mahesh Darna; A George Wilson; Emily D Denehy; Amanda Ebben; Agripina G Deaciuc; Linda P Dwoskin; Michael T Bardo; Timothy W Lefever; Jenny L Wiley; Chad J Reissig; Kia J Jackson
Journal:  Eur J Pharmacol       Date:  2017-08-26       Impact factor: 4.432

5.  Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.

Authors:  Lisa M McFadden; Greg C Hadlock; Scott C Allen; Paula L Vieira-Brock; Kristen A Stout; Jonathan D Ellis; Amanda J Hoonakker; David M Andrenyak; Shannon M Nielsen; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-10-27       Impact factor: 4.030

6.  Methamphetamine-induced changes in the object recognition memory circuit.

Authors:  Carmela M Reichel; Lauren A Ramsey; Marek Schwendt; Jacqueline F McGinty; Ronald E See
Journal:  Neuropharmacology       Date:  2011-11-18       Impact factor: 5.250

7.  3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.

Authors:  Charlotte P Magee; Christopher L German; Yasmeen H Siripathane; Peter S Curtis; David J Anderson; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2020-05-08       Impact factor: 4.030

8.  The group II metabotropic glutamate receptor agonist, LY379268, decreases methamphetamine self-administration in rats.

Authors:  Jordan T Crawford; David C S Roberts; Thomas J R Beveridge
Journal:  Drug Alcohol Depend       Date:  2013-08-02       Impact factor: 4.492

9.  Methamphetamine self-administration acutely decreases monoaminergic transporter function.

Authors:  Lisa M McFadden; Kristen A Stout; Paula L Vieira-Brock; Scott C Allen; Shannon M Nielsen; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2011-12-13       Impact factor: 2.562

10.  The effects of methamphetamine self-administration on cortical monoaminergic deficits induced by subsequent high-dose methamphetamine administrations.

Authors:  Lisa M McFadden; Glen R Hanson; Annette E Fleckenstein
Journal:  Synapse       Date:  2013-07-27       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.